Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lydia Navarrete-Galvan"'
Autor:
Lydia Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, Julie Smith-Gagen, Vincent C. Lombardi, Rebecca Merica, Dorothy Hudig
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background The NK cell line NK-92 and its genetically modified variants are receiving attention as immunotherapies to treat a range of malignancies. However, since NK-92 cells are themselves tumors, they require irradiation prior to transfer
Externí odkaz:
https://doaj.org/article/08b208ea7b0644029d4d0450d419a938
Autor:
Jennifer J.-J. Tang, Alexander P. Sung, Michael J. Guglielmo, Lydia Navarrete-Galvan, Doug Redelman, Julie Smith-Gagen, Dorothy Hudig
Publikováno v:
Antibodies, Vol 9, Iss 4, p 54 (2020)
NK cell ADCC supports monoclonal antibody anti-tumor therapies. We investigated serial ADCC and whether it could be predicted by NK phenotypes, including expression of CD16A, CD2 and perforin. CD16A, the NK receptor for antibodies, has AA158 valine o
Externí odkaz:
https://doaj.org/article/3830a81a7c394fcb823aa145c242f095
Autor:
Swati Khanna, Rachael Orlandella, Elizabeth Saputra, Sydney Matthews, Lydia Navarrete-Galvan, Sara LeMar, Joseph Dekker, Eric Poma, Chris Moore
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce7ac6b95f367636fcef37c487815b6e
https://doi.org/10.1136/jitc-2022-sitc2022.0736
https://doi.org/10.1136/jitc-2022-sitc2022.0736
Autor:
Dorothy Hudig, Lydia Navarrete-Galvan, Jennifer J.-J. Tang, Alexander P. Sung, Lucinda Bateman, Doug Redelman, Julie Smith-Gagen, Michael J. Guglielmo
Publikováno v:
Fatigue
BACKGROUND: Chronic fatigue syndrome (CFS) is an illness of unknown origin that may have familial risks. Low natural killer (NK) lymphocyte activity was proposed as a risk for familial CFS in 1998. Since then, there have been many studies of NK lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c34898fe5063335a5d949cbb0b9bc3
https://pubmed.ncbi.nlm.nih.gov/33777500
https://pubmed.ncbi.nlm.nih.gov/33777500
Autor:
Julie Smith-Gagen, Michael J. Guglielmo, Doug Redelman, Jennifer J.-J. Tang, Alexander P. Sung, Lydia Navarrete-Galvan, Dorothy Hudig
Publikováno v:
Antibodies
Volume 9
Issue 4
Antibodies, Vol 9, Iss 54, p 54 (2020)
Volume 9
Issue 4
Antibodies, Vol 9, Iss 54, p 54 (2020)
NK cell ADCC supports monoclonal antibody anti-tumor therapies. We investigated serial ADCC and whether it could be predicted by NK phenotypes, including expression of CD16A, CD2 and perforin. CD16A, the NK receptor for antibodies, has AA158 valine o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9ac739213bfafe20ee4fed19603a55